Proscia and Uppsala University Hospital, Sweden, have announced a multi-year agreement to fully digitise the region’s pathology workflows.
The Division of Laboratory Medicine at Uppsala University Hospital has selected Proscia’s Concentriq Dx digital pathology solution for full-scale digitisation and future deployment of AI applications in routine operations at scale, empowering the region’s pathologists to drive increased quality and productivity gains and unlock hidden insights to better inform patient care.
Proscia’s technology will drive Uppsala’s modernisation efforts and its goal of becoming completely digitised. The technology will support the region in achieving widespread, seamless integration with leading scanners, laboratory information systems, and image analysis applications. Proscia’s Concentriq will equip the clinical pathology laboratory at University Hospital with streamlined and intuitive workflows that ensure secure, remote access to cases and images.
“Uppsala University Hospital is propelled by its vision to become the leading university hospital creating the most value for its patients,” said senior consultant in neuropathology Irina Alafuzoff, Section Manager of Clinical Pathology, part of the laboratory medicine division at Uppsala University Hospital. “As we strive to advance our region to a digitised future, our working group including several pathologists, biomedical analysts, and representatives with IT expertise, evaluated multiple enterprise solutions and selected Proscia for its highly nimble and knowledgeable approach to computational pathology. We are confident that Concentriq’s scalable and open platform will drive us to the forefront of innovation as we work to empower the future of our laboratories.”
Proscia’s Concentriq digital pathology platform is a robust, end-to-end solution for connecting distributed teams, data and applications across the global enterprise. The flagship software is used by leading laboratories and health systems, as well as 10 of the top 20 pharmaceutical companies. With Concentriq, laboratories can tap into the interoperability and scalability required to achieve streamlined, reliable operations for pathologists and enhanced outcomes for patients.
“We are thrilled about the opportunity to invest in the Nordic region’s digitisation efforts and honoured to have been selected as Uppsala’s solution to achieve full digitisation by 2024 and elevate the region as a centre of excellence,” said David West, CEO, Proscia. “We look forward to helping Uppsala shift its pathology standard of care to a data-driven discipline and optimise their laboratory operations to drive rapid innovation within the field of pathology.”
